Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Sam Slutsky's Stock Ratings
LifeSci Capital Analyst
Sam Slutsky is an analyst at LifeSci Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
63.8%
Smart Score
Overall Average Return Percentile
96th
Number of Ratings
4
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/04/2025 | PVLA | Buy Now | Palvella Therapeutics | $88.75 | 1.41% | → $90 | Initiates | → Outperform | Get Alert | |
| 07/23/2025 | ABVX | Buy Now | Abivax | $116.02 | -12.95% | $45 → $101 | Maintains | Outperform | Get Alert | |
| 04/12/2023 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 04/05/2023 | IFRX | Buy Now | InflaRx | $0.98 | — | — | Upgrade | Market Perform → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved